TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 171.92M | 190.29M | 91.77M | 71.66M | 48.95M |
| Total Depreciation and Amortization | 30.91M | 25.89M | 24.60M | 23.73M | 21.59M |
| Total Amortization of Deferred Charges | 2.00M | 1.30M | 800.00K | -- | -- |
| Total Other Non-Cash Items | -36.03M | -43.01M | 42.94M | 41.18M | 40.15M |
| Change in Net Operating Assets | 51.42M | 18.38M | 17.88M | -21.30M | -61.30M |
| Cash from Operations | 220.23M | 192.84M | 177.99M | 115.27M | 49.38M |
| Capital Expenditure | -68.87M | -59.25M | -57.34M | -97.92M | -112.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 441.00K | 441.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -68.87M | -59.25M | -57.34M | -97.48M | -112.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.87M | 17.00M | 15.08M | 19.17M | 22.72M |
| Repurchase of Common Stock | -276.00K | -138.00K | -138.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.59M | 16.86M | 14.94M | 19.17M | 22.72M |
| Foreign Exchange rate Adjustments | 585.00K | 1.27M | 489.00K | 866.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 169.53M | 151.72M | 136.08M | 37.82M | -40.07M |